Advice

in the absence of a submission from the holder of the marketing authorisation:

dexmedetomidine (Dexdor) is not recommended for use within NHSScotland.

Indication under review: Sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Download detailed advice355KB (PDF)

Download

Medicine details

Medicine name:
dexmedetomidine (Dexdor)
SMC ID:
SMC2161
Indication:
Sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation.
Pharmaceutical company
Orion Pharma (UK) Ltd
BNF chapter
Submission type
Non submission
Status
Not recommended
Date advice published:
11 February 2019